Cargando…
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
Autores principales: | Elshahaly, Mohsen, Wheater, Gillian, Naraghi, Kamran, Tuck, Stephen P, Datta, Harish K, Ng, Wan-Fai, van Laar, Jacob M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582413/ http://dx.doi.org/10.1186/1471-2474-14-S1-A10 |
Ejemplares similares
-
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study
por: Wheater, Gillian, et al.
Publicado: (2018) -
The clinical utility of bone marker measurements in osteoporosis
por: Wheater, Gillian, et al.
Publicado: (2013) -
Bone marker reference range study: a comparison of the manufacturer’s reference range and laboratory healthy volunteer results to patients with rheumatoid arthritis
por: Wheater, Gillian, et al.
Publicado: (2013) -
Rx—The Eye of Horus
por: Walker, Clive
Publicado: (1992) -
The Eye of Horus: The Connection Between Art, Medicine, and Mythology in Ancient Egypt
por: ReFaey, Karim, et al.
Publicado: (2019)